跳至主要内容
临床试验/NCT06081608
NCT06081608尚未招募不适用

Acute Kidney Injury Among Pediatric Cancer Patients At South Egypt Cancer Institute

Assiut University0 个研究点目标入组 2 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
2
主要终点
To determine the cumulative incidence of AKI using KDIGO criteria in pediatric patients with malignancy in South Egypt Cancer Institute (SECI)

研究概览

简要总结

Cancer is the second most frequent cause of premature death in children. The incidence of pediatric cancer varies by region and country, but it is generally considered rare with an estimated 300,000 new cases diagnosed worldwide. Acute kidney injury in pediatric cancer patients refers to the sudden and often temporary loss of renal function, which can lead to a variety of complications if not treated correctly.

详细描述

  • Primary: To determine the cumulative incidence of AKI using KDIGO criteria in pediatric patients with malignancy in South Egypt Cancer Institute (SECI)
  • Secondary:
  1. Incidence of Hospital-acquired and community-acquired AKI
  2. Asses the risk factors of the incidence of AKI
  3. To determine in-hospital outcome (time to in-hospital death, length of hospital stay, and time to kidney recovery) of AKI.

This is a prospective study that will be carried out in the Paediatric Oncology and Haematological Malignancies Department including patients diagnosed with malignant tumours and hospitalized from 1st April 2023 for one year duration.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Days 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • • Children of both sexes (aged from 1 month to 18 years at diagnosis)
  • Patients with either hematological malignancies or solid tumors admitted to the Paediatric Oncology and Haematological Malignancies Department

排除标准

  • Children who had an unconfirmed cancer diagnosis.
  • Children more than 18 years at diagnosis.
  • Children with preexisting chronic kidney disease (CKD) that defined as the presence of structural or functional kidney damage that persist over minimum of three month
  • The patient underwent hematopoietic stem cell transplantation. Patients with 1 s.Cr level.
  • Patient underwent renal transplant.

结局指标

主要结局

To determine the cumulative incidence of AKI using KDIGO criteria in pediatric patients with malignancy in South Egypt Cancer Institute (SECI)

时间窗: from November 2023 till November 2024

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Amir Fathy Riad

resident doctor

Assiut University

相似试验